
Jamal Mosallam
Chief Financial Officer
Jamal is a strategic finance and operations executive with over 20 years of global experience maximizing revenue and operating margins, raising and managing debt and equity capital, and increasing shareholder value for privately held and publicly traded companies. Jamal has extensive experience in the life science, medical device, and biopharma space; most recently leading a $20M capital raise resulting in a reverse merger with a NASDAQ listed company. He also serves on the Board of STEL Technologies, a regenerative medicine company that engineers biological tissue implants for tissue replacements and repairs of musculoskeletal injuries. Earlier in his career, Jamal held various senior finance positions with Thermo Fisher Scientific.
EDUCATION
Wayne State University
MBA, Concentration in Finance
Wayne State University
BS, Accounting